80 related articles for article (PubMed ID: 15780037)
21. Reduced incidence of distant metastases and lower mortality in 1072 patients with breast cancer with a history of hormone replacement therapy.
Schuetz F; Diel IJ; Pueschel M; von Holst T; Solomayer EF; Lange S; Sinn P; Bastert G; Sohn C
Am J Obstet Gynecol; 2007 Apr; 196(4):342.e1-9. PubMed ID: 17403414
[TBL] [Abstract][Full Text] [Related]
22. Initially metastatic breast carcinoma has a distinct disease pattern but an equivalent outcome compared with recurrent metastatic breast carcinoma.
Jimeno A; Amador ML; González-Cortijo L; Tornamira MV; Ropero S; Valentín V; Hornedo J; Cortés-Funes H; Colomer R
Cancer; 2004 May; 100(9):1833-42. PubMed ID: 15112263
[TBL] [Abstract][Full Text] [Related]
23. Prognosis after regional lymph node recurrence in patients with stage I-II breast carcinoma treated with breast conservation therapy.
Harris EE; Hwang WT; Seyednejad F; Solin LJ
Cancer; 2003 Nov; 98(10):2144-51. PubMed ID: 14601083
[TBL] [Abstract][Full Text] [Related]
24. Population-based survival from cancers of breast, cervix and ovary in women in Mumbai, India.
Yeole BB; Kumar AV; Kurkure A; Sunny L
Asian Pac J Cancer Prev; 2004; 5(3):308-15. PubMed ID: 15373712
[TBL] [Abstract][Full Text] [Related]
25. Prognosis of metachronous contralateral breast cancer: importance of stage, age and interval time between the two diagnoses.
Vichapat V; Garmo H; Holmberg L; Fentiman IS; Tutt A; Gillett C; Lüchtenborg M
Breast Cancer Res Treat; 2011 Nov; 130(2):609-18. PubMed ID: 21671018
[TBL] [Abstract][Full Text] [Related]
26. Presence of a micropapillary pattern in mucinous carcinomas of the breast and its impact on the clinical behavior.
Shet T; Chinoy R
Breast J; 2008; 14(5):412-20. PubMed ID: 18673338
[TBL] [Abstract][Full Text] [Related]
27. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.
Shen Y; Yang Y; Inoue LY; Munsell MF; Miller AB; Berry DA
J Natl Cancer Inst; 2005 Aug; 97(16):1195-203. PubMed ID: 16106024
[TBL] [Abstract][Full Text] [Related]
28. The impact of lobular and ductal breast cancer histology on the metastatic behavior and long term survival of breast cancer patients.
Korhonen T; Kuukasjärvi T; Huhtala H; Alarmo EL; Holli K; Kallioniemi A; Pylkkänen L
Breast; 2013 Dec; 22(6):1119-24. PubMed ID: 23863867
[TBL] [Abstract][Full Text] [Related]
29. Lack of prognostic significance of "classic" lobular breast carcinoma: a matched, single institution series.
Viale G; Rotmensz N; Maisonneuve P; Orvieto E; Maiorano E; Galimberti V; Luini A; Colleoni M; Goldhirsch A; Coates AS
Breast Cancer Res Treat; 2009 Sep; 117(1):211-4. PubMed ID: 18629634
[TBL] [Abstract][Full Text] [Related]
30. Expression of HAb18G is associated with tumor progression and prognosis of breast carcinoma.
Liu F; Cui L; Zhang Y; Chen L; Wang Y; Fan Y; Lei T; Gu F; Lang R; Pringle GA; Zhang X; Chen Z; Fu L
Breast Cancer Res Treat; 2010 Dec; 124(3):677-88. PubMed ID: 20213083
[TBL] [Abstract][Full Text] [Related]
31. Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark.
Christiansen P; Bjerre K; Ejlertsen B; Jensen MB; Rasmussen BB; Lænkholm AV; Kroman N; Ewertz M; Offersen B; Toftdahl DB; Møller S; Mouridsen HT;
J Natl Cancer Inst; 2011 Sep; 103(18):1363-72. PubMed ID: 21881042
[TBL] [Abstract][Full Text] [Related]
32. Age at diagnosis in relation to survival following breast cancer: a cohort study.
Brandt J; Garne JP; Tengrup I; Manjer J
World J Surg Oncol; 2015 Feb; 13():33. PubMed ID: 25889186
[TBL] [Abstract][Full Text] [Related]
33. Angiosarcoma of the breast.
Vorburger SA; Xing Y; Hunt KK; Lakin GE; Benjamin RS; Feig BW; Pisters PW; Ballo MT; Chen L; Trent J; Burgess M; Patel S; Pollock RE; Cormier JN
Cancer; 2005 Dec; 104(12):2682-8. PubMed ID: 16288486
[TBL] [Abstract][Full Text] [Related]
34. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
Choi YJ; Shin YD; Song YJ
World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
[TBL] [Abstract][Full Text] [Related]
35. Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up.
Reed W; Bøhler PJ; Sandstad B; Nesland JM
Breast J; 2004; 10(3):174-80. PubMed ID: 15125740
[TBL] [Abstract][Full Text] [Related]
36. Multicentric and multifocal versus unifocal breast cancer: is the tumor-node-metastasis classification justified?
Weissenbacher TM; Zschage M; Janni W; Jeschke U; Dimpfl T; Mayr D; Rack B; Schindlbeck C; Friese K; Dian D
Breast Cancer Res Treat; 2010 Jul; 122(1):27-34. PubMed ID: 20454925
[TBL] [Abstract][Full Text] [Related]
37. Correlation of hormone receptors with Her-2 Neu protein expression and the histological grade in invasive breast cancers in a cohort of Saudi Arabia.
Arafah M
Turk Patoloji Derg; 2012; 28(1):38-43. PubMed ID: 22207430
[TBL] [Abstract][Full Text] [Related]
38. Investigating the correlation between hospital of primary treatment and the survival of women with breast cancer.
Hébert-Croteau N; Brisson J; Lemaire J; Latreille J; Pineault R
Cancer; 2005 Oct; 104(7):1343-8. PubMed ID: 16080144
[TBL] [Abstract][Full Text] [Related]
39. Resection of liver metastases in patients with breast cancer: survival and prognostic factors.
van Walsum GA; de Ridder JA; Verhoef C; Bosscha K; van Gulik TM; Hesselink EJ; Ruers TJ; van den Tol MP; Nagtegaal ID; Brouwers M; van Hillegersberg R; Porte RJ; Rijken AM; Strobbe LJ; de Wilt JH;
Eur J Surg Oncol; 2012 Oct; 38(10):910-7. PubMed ID: 22682709
[TBL] [Abstract][Full Text] [Related]
40. Type of breast cancer diagnosis, screening, and survival.
Cedolini C; Bertozzi S; Londero AP; Bernardi S; Seriau L; Concina S; Cattin F; Risaliti A
Clin Breast Cancer; 2014 Aug; 14(4):235-40. PubMed ID: 24703317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]